CSURGSU logo

Centenial Surgical Suture Ltd

CSURGSU·BSE·
₹71.25▲ +0.00 (+0.00%)
Market Cap25.99 Cr
PE Ratio-24.50
Volume1
Day High - Low71.25 - 71.25
52W High-Low124.90 - 71.25

Centenial Surgical Suture Ltd (CSURGSU): company summary

The company's annual revenue grew 0.6% to ₹54 crore, but net profit turned into a loss of ₹2 crore, widening from a ₹1 crore loss the previous year.

Centenial Surgical Suture Ltd (CSURGSU) is a micro-cap Healthcare company valued at ₹26 crore operating in Medical Equipment on the NSE and BSE.

Recent price move
Centenial Surgical Suture Ltd last traded at ₹71.25, unchanged on the day.
Recent developments
On 2026-06-30, the company reported a net profit of ₹1 crore for the latest quarter, reversing a net loss of ₹0 crore in the same quarter a year earlier. This marks a significant turnaround in the quarter's profitability compared to the prior year.
Financial performance
The company's annual revenue grew 0.6% to ₹54 crore, but net profit turned into a loss of ₹2 crore, widening from a ₹1 crore loss the previous year. In the latest quarter, revenue rose 18.5% to ₹15 crore, and net profit swung from a ₹0 crore loss to a profit of ₹1 crore, showing improvement in the recent quarter.
Valuation multiples
A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 1.32 times book value.
Things to watch
The company reported a net loss of ₹2 crore in its latest financial year, widening from a ₹1 crore loss the previous year. The net profit margin deteriorated to -4.1%, down 1.4 percentage points from -2.7% in the prior year. The return on equity is negative at -7.7%, indicating poor profitability relative to equity.
Where it stands
The company ended its latest financial year with a net loss of ₹2 crore, but the latest quarter showed a net profit of ₹1 crore, reversing a previous loss. The most significant movement was the swing from a net loss to a profit in the latest quarter, highlighting a recent improvement in performance.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
3.1/10
Poor
Fair Value
Sign in to see
ROE
-7.72%
Weak
P/E
-24.50x
Loss-making
Debt / Equity
0.38
Moderate
Industry
Healthcare
Medical Equipment
Overall View
Poor

Price performance

52W₹71.25
₹124.90
DocStoX take

Supported by risk (6.5) and valuation (6.0), but held back by momentum (0.0).

DocStoX score

Low confidence
3.1
/10
Poor
Quality
Weak
ROE -7.7%
Valuation
Fair
P/B 1.3× on assets (no earnings to value)
Growth
Slow
Revenue +7.8% 5Y CAGR
Risk
Moderate
D/E 0.38
Momentum
Weak
0% of 52-week range

At a glance

Market Cap
₹26 Cr
52W High / Low
₹125 / ₹71
Dividend Yield
0.00%
Promoter Holding
46.89%
EPS (TTM)
₹-6.04
Book Value
₹78.26

Key highlights

  • Loss-making — no meaningful P/E
  • Loss-making in some of the last 5 years
0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Medical Equipment

Centenial Surgical Suture Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.